Statement from the Minister of Health and the Minister of Industry on Advancing Canada's Pharmaceutical and Life Sciences Sector

Imported from official source

Announcement

Safety Classified by Officially

The Task Force brought together senior leaders and experts from the pharmaceutical sector to explore innovative, made-in-Canada solutions. These productive discussions and engagements have deepened our collective understanding of how health, innovation and regulations are interconnected and work together to support better health outcomes and a growing economy.

July 24, 2026 | Ottawa, Ontario | Health Canada

As the work of the Pharmaceutical and Life Sciences Sector Task Force (Task Force) comes to a close, we welcome the report published today and thank the Task Force for its thoughtful discussions on how Canada can strengthen the competitiveness and long-term sustainability of its pharmaceutical and life sciences sector, improve reliable and sustainable access to medicines, and support economic growth.

The Task Force brought together senior leaders and experts from the pharmaceutical sector to explore innovative, made-in-Canada solutions. These productive discussions and engagements have deepened our collective understanding of how health, innovation and regulations are interconnected and work together to support better health outcomes and a growing economy.

More specifically, members discussed topics such as:

  • Access to and affordability of pharmaceuticals;
  • Pharmaceutical sovereignty and the security of Canada's supply;
  • Regulatory approaches for supporting innovation and resilience;
  • Modernization of decision-making processes, with a focus on data and evidence;
  • Research, innovation, and the pharmaceutical development pipeline; and
  • Economic growth, commercialization, and scale-up of life sciences firms.
  • The Government of Canada will carefully consider the Task Force's recommendations as part of its efforts to improve affordable access to pharmaceuticals while strengthening the growth and resilience of Canada's life sciences sector.

    This is an extract. The publication continues at the source.

    Source: Health Canada. Licence

    Read the original at the source: https://www.canada.ca/en/health-canada/news/2026/07/statement-from-the-minister-of-health-and-the-minister-of-industry-on-advancing-canadas-pharmaceutical-and-life-sciences-sector.html

    Officially imported this from Health Canada’s own source and shows an extract. If you work there, claiming the profile and verifying the domain lets you choose to show the full text here.

    Provenance

    Organization
    Health Canada — imported from official source
    Official source
    https://api.io.canada.ca/io-server/gc/news/en/v2?dept=departmentofhealth&sort=publishedDate&orderBy=desc&publishedDate%3E=2021-07-23&pick=50&format=atom&atomtitle=Health%20Canada ATOM
    Imported
    October 03, 2026 20:43
    Versions
    1 recorded
    Identity
    https://www.canada.ca/en/health-canada/news/2026/07/statement-from-the-minister-of-heal...

    Officially records where a publication came from, not whether it is true. Imported records are reproduced from an organization's own official source.